Side effects
Breast cancer does not appear to be brought on by birth control pills. If you have any thoughts of harming yourself, contact your healthcare provider right away. The following symptoms should be reported to your doctor right away: persistent leg pain, sudden shortness of breath, sudden blindness, partial or complete, severe chest pain, weakness or numbness in an arm or leg, or trouble speaking, yellowing of the skin or eyes. The most typical side effects of birth control pills are: spotting or bleeding between periods, nausea, breast tenderness, headache, and nausea. However, because some breast cancers are hormone-sensitive, you shouldn't use birth control if you currently have breast cancer or have in the past. This might, however, be the result of other things, like having more sexual partners. It is possible to pass away from a blood clot-related issue, such as a heart attack or stroke. Less frequent negative effects include: acne, decreased sexual desire, bloating, or fluid retention, blotchy skin darkening, particularly on the face, high blood sugar, particularly in diabetic women, high fat (cholesterol; triglyceride) levels in the blood, and depression, particularly if you have previously experienced depression. Birth control pills, like pregnancy, put women at greater risk for life-threatening blood clots, especially if they also have other risk factors like smoking, being overweight, or being older than 35. Weight changes Contact lens intolerance issues Can birth control cause cancer? Blood clots in the legs (thrombophlebitis), lungs (pulmonary embolus), eyes (loss of vision), heart (heart attack), and brain (stroke) are a few examples of serious clots. Some women who use birth control pills may also experience the following conditions: high blood pressure Gallbladder issues Rare cancerous or non-cancerous liver tumors All of these conditions are uncommon in healthy women. The risk is greatest when you first start taking birth control pills and when you start taking the same or a different type of birth control after a month or more of inactivity. Cervical cancer risk may be slightly increased for female birth control pill users.
Interactions
The anticonvulsant lamotrigine, used to treat epilepsy, may interact with birth control pills. You should talk to your doctor before taking Yasmin if you are currently receiving daily, long-term treatment for a chronic condition with any of the following medications: NSAIDs (ibuprofen, naproxen, and others) Potassium-sparing diuretics (spironolactone, and others) Potassium supplementation ACE inhibitors (captopril, enalapril, lisinopril, and others) Angiotensin- Consider using a different method of birth control if you take medications that could reduce the effectiveness of birth control pills, such as John's wort or topiramate. Barbiturates, Bosentan, Carbamazepine, Felbamate, Griseofulvin, Oxcarbazepine, Phenytoin, Rifampin, and St. John's wort are a few other drugs and herbal remedies that may reduce the effectiveness of birth control pills. Your doctor may need to modify the lamotrigine dosage because this could increase the likelihood of seizures.
Contraindications
Smoking increases your risk of serious cardiovascular side effects (heart and blood vessel problems) from birth control pills, including death from heart attack, blood clots or stroke. This risk increases with age and the number of cigarettes you smoke. WARNING TO SMOKING WOMEN Do not use Yasmin if you smoke and are older than 35.
Yaz, Yasmin Settlements Continue to Move Forward in MDL More than four years after the first Yaz and Yasmin settlements were reported, Bayer continues to reach deals to resolve hundreds of additional cases over their controversial birth control pill.
The warning states: "Data from a large, prospective cohort safety study of various COCs (combined oral contraceptives) suggest that this increased risk, as compared to that in non-COC users, is greatest during the first 6 months of COC use. • Regardless as to whether Bayer Pharmaceuticals intended Natazia as a replacement for the Yasmin and Yaz duo as an expansion to their product line or as a needed replacement for an allegedly problematic product, it appears as if Natazia contraceptive is beset with concerns of its own. Bayer's Natazia Oral Contraceptive Associated with Serious Adverse Events Washington, DC: Natazia (estradiol valerate and estradiol valerate/dienogest), a fourth generation oral contraceptive made by pharmaceutical giant Bayer HealthCare Pharmaceuticals, Inc, was FDA-approved on March 15, 2012, for the treatment of heavy menstrual bleeding that is not caused by diagnosed conditions of the uterus. The excess risk of thromboembolic events is highest during the first year of use of COC." The following safety information was included in a press release from Bayer following the release of Natazia on the US market, in 2010: "The use of Natazia is associated with increased risks of several serious conditions including venous and arterial thrombotic and thromboembolic events (such as myocardial infarction, thromboembolism, stroke), hepatic neoplasia, gallbladder disease, hypertension, ruptured ovarian cyst and uterine leiomyoma.
“According to studies by the RIETE group,” says Ángeles Blanco, “two-thirds of women with venous thromboembolism experience the disease due exclusively to the use of contraception, as in the case of Rohrer.” Given the situation, the expert recommends that women not take a hormonal contraceptive on their own initiative: “Contraceptives must be prescribed by a specialist. She states that she is often short of breath, cannot practice sports and has to wear compression stockings when traveling by car. Contraceptive drugs and VTE “Yasminelle is a combined hormonal contraceptive,” explains Ángeles Blanco, an internist at the Hospital Reina Sofía of Córdoba, “and like most of the medications we regularly use, it usually has side effects. As a general rule, the benefit obtained from these medications outweighs the risk of causing adverse reactions, and for this reason the medicine agencies approve their use.” “The number of women who experience venous thromboembolism related to contraceptives is low in relation to the large number of women who use them,” continues Dr. Blanco. “The specialists could not explain how a healthy woman of that age could suddenly suffer pulmonary embolism,” said the young woman.
Yaz Lawsuits Summarized Prescription drug companies owe a duty to patients to sell prescription drugs that are safe and effective, and fully disclose the risks associated with their drugs. Issue: Blood clots and other dangerous side effects Yaz Lawsuits and Settlements – Update Serious side effects have been linked to the birth control drugs Yaz and Yasmin, and their generic versions Gianvi and Ocella. These side effects include strokes, heart attacks and blood clots that form inside a vein, known as deep vein thrombosis.
During this time, usually after 2 or 3 days, you will normally have your ‘period’ which is called a withdrawal bleed. For example, if you took your last pill on a Sunday, start your next 21 day packet on the Monday of the week following your 7 day break. Then continue to take your pill each day following the direction of the arrows on the pack until you have taken all 21.
Preclinical studies in animals and in vitro have shown that drospirenone has no androgenic, estrogenic, glucocorticoid and antiglucocorticoid activity. Thereafter one tablet must be taken daily for 28 days following the direction shown by the arrows. Withdrawal bleeding usually starts on day 2 to 3 after starting the inactive (hormone-free) tablets and may not have finished before the next pack is started. The drug proved more than 99% effective in preventing pregnancy, with only one pregnancy occurring in 3,201 cycles of 326 Yasmin users.
Two Newer Studies Found An Increased Venous Thromboembolism (VTE) Risk in Yasmin Users Compared To Levonorgestrel-Containing Birth Control Pills UPDATE : New research suggests that women who use oral contraceptives (OCs) containing drospirenone (DRSP) have an increased risk of venous thromboembolism (VTE) compared with users of birth control pills containing levonorgestrel . • DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects Now, a March 26, 2010 press release issued by Bayer HealthCare and Bayer Schering Pharma gives us an update on this safety review in the European Union (EU), in particular the part which focused on the risk for venous thromboembolism (VTE) in Yasmin users. [Van Hylckama Vlieg publication] Also from this Bayer press release about the Yasmin label change in Europe we get this "interpretation" of those four medical studies: Bayer sponsored two large observational post authorization safety studies (EURAS and Ingenix) on combined oral contraceptive (COC) use for European and US (Food and Drug Administration) Health Authorities. Bayer Schering Pharma is working with the PhVWP on a reanalysis of some of these data.